Sustainability

WeCare

Inspired by our purpose to revolutionise care for people and planet, our sustainability roadmap to 2030, WeCare, guides us and lends structure to our sustainability efforts. It is a driver for growth, innovation and productivity and an essential part of our employee value proposition.

We are committed to transforming our business to become a global leader in sustainable healthcare. This transformation entails embedding sustainability into every aspect of our operations, offers, and partnerships.

Creating shared value

True transformation happens when social, environmental and economic dimensions are seamlessly integrated into our business strategy. This holistic approach ensures that our actions generate value across all three areas. By embedding sustainability into everything we do, we aim to improve health and wellbeing for more people today while safeguarding the planet’s resources for future generations.

Collaboration for lasting change

At Mölnlycke, we differentiate ourselves by collaborating across our value chains to deliver lasting benefits for society and the environment. Together, we are committed to  eliminating GHG emissions, waste, and harm, and the delivery of positive societal value. Our ambition is to ensure a future where healthcare is not only efficient but truly sustainable.

Read more on how to partner with us


Commitment to global goals

Our corporate goals are aligned with the United Nations Sustainable Development Goals (SDGs) most relevant to Mölnlycke. We are committed to making a measurable, focused contribution to these global objectives, ensuring that our progress benefits both people and the planet.

 

Revolutionising care

  • For people

    Care for people

  • For planet

    Care for planet

Governance

Ethical business culture

We set high standards of ethics and responsibility in our business and act with integrity and care for human rights throughout our value chain. Mölnlycke is a signatory of the UN Global Compact and is committed to responsible business practices. For details see here.

Transparent reporting for informed sustainable decisions

Transparency in reporting is central to our sustainability efforts. We ensure data is accurate, accessible and actionable for our customers and other stakeholders. By refining how we communicate, we address a core need for clarity, enabling informed, sustainable choices across the healthcare sector.

Download Mölnlycke's Annual Report 2024

"Recognising the profound and ongoing pressure on environment, society and global healthcare systems in particular, Mölnlycke are accelerating our transformation to deliver sustainable healthcare solutions. We are uniquely positioned to improve patient lives while reducing the environmental impact of healthcare."

Caterina Camerani VP Sustainability

Double Materiality Assessment

In 2024, we conducted a Double Materiality Assessent (DMA) to enhance our understanding of material sustainability-related impacts, risks and opportunities, in alignment with CSRD requirements for identifying and evaluating ESG-related factors. The validated DMA will inform Mölnlycke’s sustainability roadmap, WeCare, and disclosures. 

The results of the DMA are presented in the link below. The scope of the assessment encompassed all operations of Mölnlycke, including subsidiaries and joint ventures, as well as its upstream and downstream value chain, and was global in geographic scope.

Learn more

Our commitment to reach Net Zero by 2050

We have formalised our climate change mitigation efforts by publicly committing to the Science Based Targets Initiative (SBTi), and securing their validation of our near-term climate targets, as well as the Net Zero target. See below what targets have been validated by SBTi.

  • Reducing absolute scope 1 and 2 GHG emissions by 50% by 2030 from a 2021 base year.

  • Increasing active annual sourcing of renewable electricity from 23% in 2021 to 100% by the end of 2024 and continuing active annual sourcing of 100% of renewable electricity through 2030.

  • Reducing absolute scope 3 GHG emissions from purchased goods and services (cat. 1), fuel and energy related activity (cat. 3), upstream transportation and distribution (cat. 4) and waste generated in operations (cat. 5) by 20% by 2028 from a 2021 base year.

  • Having 63% of our suppliers by emissions covering purchased goods and services (cat. 1) capital goods (cat. 2), and upstream transportation and distribution (cat. 4) committed to the Science Based Targets Initiative by 2028.

  • Mölnlycke is committed to reducing absolute Scope 1 and 2 GHG emissions by 90% by 2050 compared to the 2021 base year and to reduce Scope 3 GHG emissions by 97% per tonne of sold product within the same timeframe.

Milestones on the way to Net Zero

 

2016: Scope 1 and 2 GHG emissions measured and baseline established.

2021: Materiality analysis and development of WeCare (2030 sustainability roadmap).

2021: Upstream and downstream scope 3 GHG emissions measured and baseline established.

2021: First range of BARRIER® surgical drapes launched with demonstrable reductions in emissions.

2022: Commitment to SBTi and nine manufacturing sites operating on 100% renewable electricity.

2023: Validation of near-term GHG emission reduction targets by SBTi.

2023: Sustainable Product Portfolio Assessment conducted for Operating Room Solutions and Antiseptics portfolios.

2024: 100% renewable electricity at all manufacturing sites and the headqarters

2025: Net Zero by 2050 target validated by SBTi.

Sustainability news

See all news

Select country

Get knowledge, learn about our products, get support and more.

Corporate

No markets

Go to {{ currentMarket?.displayName }}

Find jobs, our financial reports and more.

Mölnlycke corporate